Cart
sales@molnova.com
4-(4-Methoxyphenyl)-2-butanone
CAS No. 104-20-1
4-(4-Methoxyphenyl)-2-butanone( Anisylacetone )
Catalog No. M22648 CAS No. 104-20-1
4-(4-Methoxyphenyl)-2-butanone is an effective lure for the male melon fly.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-(4-Methoxyphenyl)-2-butanone
-
NoteResearch use only, not for human use.
-
Brief Description4-(4-Methoxyphenyl)-2-butanone is an effective lure for the male melon fly.
-
Description4-(4-Methoxyphenyl)-2-butanone is an effective lure for the male melon fly.
-
In Vitro——
-
In Vivo——
-
SynonymsAnisylacetone
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number104-20-1
-
Formula Weight178.2
-
Molecular FormulaC11H14O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc(CCC(C)=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hymavathi A , Babu K S , Naidu V G M , et al. Bioactivity-guided isolation of cytotoxic constituents from stem-bark of Premna tomentosa[J]. Bioorganic & medicinal chemistry letters, 2009, 19(19):5727-5731.
molnova catalog
related products
-
BMS-3
BMS-3 is a potent?LIMK?inhibitor with?IC50s of 5 nM and 6 nM for?LIMK1?and?LIMK2, respectively.
-
E-I-L-D-V, human, bo...
EILDV (human, bovine, rat) is an analogue of the active pentapeptide. EILDV (human, bovine, rat) has active tripeptide amino acid sequence LDV that is conserved in human, bovine, rat. EILDV (human, bovine, rat) can be used for the research of cell adhesion.
-
Toddaculin
Toddaculine may be beneficial for the prevention and treatment of osteoporosis, it can not only inhibit the differentiation of osteoclasts via activation of the NF-κB, ERK 1/2, and p38 MAPK signaling pathways.
